A Phase 1/2 Study of the Angiogenesis Inhibitor Sorafenib in Cervical Cancer Patients Treated With Radiation Therapy

Autor:	Ivan Yeung, Kathy Han, L. Manchul, Michael Milosevic, Richard P. Hill, Helen Mackay, Naz Chaudary, T.W. Fyles, Amit M. Oza, S. Kim, Carol A. Townsley, Wilfred Levin
Rok vydání:	2014
Předmět:	Oncology Cervical cancer Sorafenib Cancer Research medicine.medical_specialty Radiation business.industry medicine.medical_treatment medicine.disease Angiogenesis inhibitor Radiation therapy Internal medicine Medicine Radiology Nuclear Medicine and imaging business medicine.drug
Zdroj:	International Journal of Radiation Oncology*Biology*Physics. 90:S187-S188
ISSN:	0360-3016
DOI:	10.1016/j.ijrobp.2014.05.717
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0e13ed4ff65f733dbe24360a93c3660d https://doi.org/10.1016/j.ijrobp.2014.05.717 Zobrazit plný text záznamu